Latest filing published 07 Aug 2014 for Aldeyra Therapeutics, Inc., €8,272.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +88.0%Entry US$4.32 · Close at T+365 US$8.12
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
C. Boyd Clarke: trading record in brief
C. Boyd Clarke discloses dealings in Aldeyra Therapeutics, Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 7 May 2014 and the latest from 6 August 2014.
Every open-market trade on record is a purchase: 2 purchases worth €80k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Most recently, on 7 August 2014, the filings show an open-market purchase worth €8,272 in Aldeyra Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to C. Boyd Clarke
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,000 shares@ US$3.69Common StockSEC:0001209191-14-051194:0Canonical exit: 4 Nov 2014 (T+90)
1 of 1 declaration
